Apollo Hospitals' Stock Dipped by 8% as Deal with Advent Raises Valuation Concerns

Apollo Hospitals Partners with Advent International

Apollo Hospitals announces a partnership with Advent International, raising ₹2,475 crore for Apollo HealthCo. Concerns arise over Apollo 24/7's valuation, causing an 8% stock drop.

Investment Details

Advent International invests $300 million, acquiring a 12.1% stake in the merged entity. The deal values Apollo HealthCo at ₹22,481 crore, with Apollo 24/7 valued at ₹14,478 crore.

Click Here

Strategic Merger

Apollo HealthCo plans to merge with Keimed, a wholesale pharma distribution business. The merger aims to enhance operations and expand services over the next 24 to 30 months.

Market Response

Apollo Hospitals' stock fell by 8% amid investor concerns about valuation. The partnership with Advent International signals growth opportunities but raises market uncertainties.

Open Demat